SCOR SE

XTRA:SDRC Stock Report

Market Cap: €4.3b

SCOR Valuation

Is SDRC undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of SDRC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: SDRC (€24.1) is trading below our estimate of fair value (€82.32)

Significantly Below Fair Value: SDRC is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for SDRC?

Key metric: As SDRC is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for SDRC. This is calculated by dividing SDRC's market cap by their current revenue.
What is SDRC's PS Ratio?
PS Ratio0.3x
Sales€15.62b
Market Cap€4.32b

Price to Sales Ratio vs Peers

How does SDRC's PS Ratio compare to its peers?

The above table shows the PS ratio for SDRC vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average0.7x
HNR1 Hannover Rück
1.1x2.5%€28.9b
MUV2 Münchener Rückversicherungs-Gesellschaft in München
1x6.9%€62.6b
WUW Wüstenrot & Württembergische
0.2xn/a€1.1b
TLX Talanx
0.4x8.5%€20.3b
SDRC SCOR
0.3x9.5%€4.3b

Price-To-Sales vs Peers: SDRC is good value based on its Price-To-Sales Ratio (0.3x) compared to the peer average (0.7x).

Price to Sales Ratio vs Industry

How does SDRC's PS Ratio compare vs other companies in the European Insurance Industry?

2 CompaniesPrice / SalesEstimated GrowthMarket Cap
SDRC 0.3xIndustry Avg. 1.0xNo. of Companies12PS00.61.21.82.43+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: SDRC is good value based on its Price-To-Sales Ratio (0.3x) compared to the European Insurance industry average (1x).

Price to Sales Ratio vs Fair Ratio

What is SDRC's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SDRC PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.3x
Fair PS Ratio0.4x

Price-To-Sales vs Fair Ratio: SDRC is good value based on its Price-To-Sales Ratio (0.3x) compared to the estimated Fair Price-To-Sales Ratio (0.4x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst SDRC forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€24.10
€25.99
+7.9%
16.6%€36.00€19.00n/a15
Nov ’25€19.68
€25.59
+30.0%
21.7%€37.00€18.00n/a15
Oct ’25€19.83
€25.65
+29.4%
22.1%€37.00€18.00n/a15
Sep ’25€18.85
€26.05
+38.2%
22.4%€37.00€18.00n/a15
Aug ’25€18.73
€27.89
+48.9%
19.3%€37.00€19.00n/a15
Jul ’25€24.44
€33.75
+38.1%
9.3%€39.00€27.00n/a15
Jun ’25€26.48
€33.96
+28.2%
8.1%€39.00€28.00n/a15
May ’25€31.08
€34.79
+11.9%
9.2%€40.00€28.00n/a15
Apr ’25€32.07
€34.47
+7.5%
9.5%€40.00€28.00n/a15
Mar ’25€27.75
€32.99
+18.9%
7.0%€37.00€27.00n/a16
Feb ’25€27.92
€32.96
+18.0%
7.1%€37.00€27.00n/a16
Jan ’25€26.50
€32.91
+24.2%
8.1%€37.00€27.00n/a16
Dec ’24€28.74
€32.91
+14.5%
8.1%€37.00€27.00n/a16
Nov ’24€29.21
€31.97
+9.4%
12.9%€37.00€23.50€19.6816
Oct ’24€29.35
€31.28
+6.6%
11.9%€36.40€23.50€19.8316
Sep ’24€28.25
€30.68
+8.6%
11.4%€36.00€23.50€18.8516
Aug ’24€27.40
€30.68
+12.0%
11.4%€36.00€23.50€18.7316
Jul ’24€26.80
€27.87
+4.0%
14.9%€35.00€20.00€24.4417
Jun ’24€24.52
€27.75
+13.2%
14.5%€34.00€20.00€26.4817
May ’24€22.98
€26.63
+15.9%
11.9%€32.00€20.00€31.0817
Apr ’24€22.38
€26.69
+19.2%
12.1%€32.00€20.00€32.0717
Mar ’24€23.38
€25.68
+9.8%
16.0%€32.00€17.50€27.7516
Feb ’24€22.16
€25.43
+14.7%
15.9%€32.00€17.50€27.9216
Jan ’24€21.76
€23.76
+9.2%
17.7%€30.00€16.50€26.5016
Dec ’23€18.82
€23.73
+26.1%
17.8%€30.00€16.50€28.7416
Nov ’23€15.23
€23.60
+55.0%
18.5%€30.00€16.00€29.2116

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

AXA

€72.3b

Through its subsidiaries, provides insurance, asset management, and banking services worldwide.

AXA

€34.20

7D

-0.6%

1Y

20.7%

Mapfre

€8.0b

Engages in insurance, finance, securities, investment, and services business worldwide.

CMA

€4.96

7D

-0.4%

1Y

27.2%

Mapfre

€8.0b

Engages in insurance, finance, securities, investment, and services business worldwide.

CMAB

€2.58

7D

-1.1%

1Y

27.1%